{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T21:40:58Z","timestamp":1649108458950},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.2169\/internalmedicine.0448-17","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T17:26:44Z","timestamp":1520530004000},"page":"2197-2201","source":"Crossref","is-referenced-by-count":0,"title":["Budd-Chiari Syndrome and Esophageal Achalasia: Unrecognized Intrahepatic Cholangiocarcinoma Invading Multiple Organs"],"prefix":"10.2169","volume":"57","author":[{"given":"Keisuke","family":"Kakisaka","sequence":"first","affiliation":[{"name":"Division of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Endo","sequence":"additional","affiliation":[{"name":"Division of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Molecular Diagnostic Pathology, Iwate Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Molecular Diagnostic Pathology, Iwate Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamotsu","family":"Sugai","sequence":"additional","affiliation":[{"name":"Department of Molecular Diagnostic Pathology, Iwate Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Takikawa","sequence":"additional","affiliation":[{"name":"Division of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 8: 512-522, 2011.","DOI":"10.1038\/nrgastro.2011.131"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology 54: 173-184, 2011.","DOI":"10.1002\/hep.24351"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60: 1268-1289, 2014.","DOI":"10.1016\/j.jhep.2014.01.021"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145: 1215-1229, 2013.","DOI":"10.1053\/j.gastro.2013.10.013"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 2017 (Epub ahead of print).","DOI":"10.1038\/nrclinonc.2017.157"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Banales JM, Cardinale V, Carpino G, et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol 13: 261-280, 2016.","DOI":"10.1038\/nrgastro.2016.51"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. MacNicholas R, Olliff S, Elias E, Tripathi D. An update on the diagnosis and management of Budd-Chiari syndrome. Expert Rev Gastroenterol Hepatol 6: 731-744, 2012.","DOI":"10.1586\/egh.12.56"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Okuda H, Yamagata H, Obata H, et al. Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol 22: 1-9, 1995.","DOI":"10.1016\/0168-8278(95)80252-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rajani R, Melin T, Bjornsson E, et al. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience. Liver Int 29: 253-259, 2009.","DOI":"10.1111\/j.1478-3231.2008.01838.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Seijo S, Plessier A, Hoekstra J, et al. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology 57: 1962-1968, 2013.","DOI":"10.1002\/hep.26306"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mahmoud AE, Mendoza A, Meshikhes AN, et al. Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. QJM 89: 37-43, 1996.","DOI":"10.1093\/oxfordjournals.qjmed.a030135"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Boeckxstaens GE, Zaninotto G, Richter JE. Achalasia. Lancet 383: 83-93, 2014.","DOI":"10.1016\/S0140-6736(13)60651-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Campo SM, Lorenzetti R, de Matthaeis M, et al. Palliation with oesophageal metal stent of pseudoachalasia from gastric carcinoma at the cardia: a case report. Diagn Ther Endosc 2009: 791627, 2009.","DOI":"10.1155\/2009\/791627"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Pastor DM, Eggers AD, Drabick JJ, Loughran TP, Bayerl MG, Shope TR. Retroperitoneal diffuse large B-cell lymphoma presenting as pseudoachalasia. J Clin Oncol 28: e184-e187, 2010.","DOI":"10.1200\/JCO.2009.25.8715"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Paulsen JM, Aragon GC, Ali MA, Brody FJ, Borum ML. Pseudoachalasia secondary to metastatic breast carcinoma. Dig Dis Sciences 55: 1179-1181, 2010.","DOI":"10.1007\/s10620-009-0809-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sousa RG, Figueiredo PC, Pinto-Marques P, et al. An unusual cause of pseudoachalasia: the Alport syndrome-diffuse leiomyomatosis association. Eur J Gastroenterol Hepatol 25: 1352-1357, 2013.","DOI":"10.1097\/MEG.0b013e328361dd17"},{"key":"17","unstructured":"17. Bandyopadhyay SK, Sarkar N, Ghosh S, Dasgupta S. Cholangiocarcinoma presenting with recurrent venous thrombosis. J Assoc Physicians India 51: 824-825, 2003."},{"key":"18","unstructured":"18. De BK, De KK, Sen S, et al. Etiology based prevalence of Budd-Chiari syndrome in eastern India. J Assoc Physicians India 48: 800-803, 2000."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Katoh M, Shigematsu H. Primary liver carcinoma complicating membranous obstruction of the inferior vena cava. Pathol Int 49: 253-257, 1999.","DOI":"10.1046\/j.1440-1827.1999.00856.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kwon OS, Jun DW, Kim SH, et al. Distant skeletal muscle metastasis from intrahepatic cholangiocarcinoma presenting as Budd-Chiari syndrome. World J Gastroenterol 13: 3141-3143, 2007.","DOI":"10.3748\/wjg.v13.i22.3141"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Law JK, Davis J, Buckley A, Salh B. Intrahepatic cholangiocarcinoma presenting as the Budd-Chiari syndrome: a case report and literature review. Can J Gastroenterol 19: 723-728, 2005.","DOI":"10.1155\/2005\/943269"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shimonishi T, Miyazaki K, Nakanuma Y. Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver. Histopathology 37: 55-63, 2000.","DOI":"10.1046\/j.1365-2559.2000.00932.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Woodfield CA, Levine MS, Rubesin SE, Langlotz CP, Laufer I. Diagnosis of primary versus secondary achalasia: reassessment of clinical and radiographic criteria. AJR Am J Roentgenol 175: 727-731, 2000.","DOI":"10.2214\/ajr.175.3.1750727"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ponds FA, van Raath MI, Mohamed SMM, Smout A, Bredenoord AJ. Diagnostic features of malignancy-associated pseudoachalasia. Aliment Pharmacol Ther 45: 1449-1458, 2017.","DOI":"10.1111\/apt.14057"},{"key":"25","unstructured":"25. Tracey JP, Traube M. Difficulties in the diagnosis of pseudoachalasia. Am J Gastroenterol 89: 2014-2018, 1994."},{"key":"26","unstructured":"26. Mertens JC, Rizvi S, Gores GJ. Targeting cholangiocarcinoma. Biochim Biophys Acta 2017."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/15\/57_0448-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T00:47:00Z","timestamp":1533343620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/15\/57_0448-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":26,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0448-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]}}}